HUGE NEWS Neil delivering on plans! Solaris Signs

New Post Public Reply Private Reply Replies (0) Message Board
Pugilista
471
HUGE NEWS Neil delivering on plans!

Solaris Signs Definitive Agreements to Acquire migme, Building on Previous PixelMags Acquisition
NEW YORK, NY-(Marketwired - Apr 20, 2017) - Solaris Power Cells, Inc. ("Solaris" or the "Company" (OTCQB: SPCL), a growth focused digital media holding company engaged in the acquisition and management of overlooked and undervalued media properties, announces that it has signed definitive agreements to acquire migme (ASX: MIG) - one of Asia's fastest growing social media platforms, with approximately 35 million monthly active users (MAU's).


Solaris is adding to its media technology holdings, notably distribution-as-a-service company PixelMags, which takes publishers' content and automatically formats and natively distributes across platforms.


"This agreement shows our acquisition strategy is starting to yield positive results. After nearly ten months since acquiring PixelMags, we're announcing our second acquisition and remain excited about the combined potential," stated Neil Kleinman, CEO of Solaris. "This acquisition will add one of Asia's fastest growing social platforms. Approximately 110 employees will be added to the Solaris team who will play a pivotal role in the future success of the company."


migme is a global digital media company with a large footprint in Southeast Asia, the fastest growing global mobile market. The platform allows stars and fans to interact together in thousands of digital chat rooms, driving longer user sessions than most other social networks. With a quarterly growth rate of 30%, migme is soon expected to join the ranks of Asia's largest social media peers like Meitu in China and Hike in India.


Under the definitive agreements, Solaris will acquire all issued capital in Project Goth, Inc., a subsidiary of migme, which owns the operating companies, including the company's portfolio of intellectual property. Solaris aims to integrate migme's branded app and other properties - dating app LoveByte, artist management community alivenotdead, social news site Hipwee and ecommerce services through Sold and Shopdeca.


The agreement is subject to Solaris becoming current in its financial and SEC reporting obligations, and other conditions. Management believes the transaction will close by June 15th.


Steven Goh, CEO of migme, said, "The proposed transaction provides an opportunity for migme to be more fairly valued on an exchange that better understands technology companies, with a clear peer group to be valued against. We look forward to working with Neil and the Solaris team in creating value for all shareholders."


About Solaris Power Cells
Solaris Power Cells, Inc. (SPCL) is a diversified holding company focused on the acquisition and management of undervalued digital media assets. Formerly focused on developing lithium battery technology for commercial applications, the Company currently holds a library of Intellectual Property surrounding digital distribution. The portfolio company PixelMags is a leading distribution-as-a-service company which takes publishers' content, formats and natively distributes to the varied Digital Newstands such as Apple, Google, Readr platforms.


About migme Limited
migme Limited (ASX: MIG) (WKN: A117AB) is a mobile digital media company capturing growth in global emerging markets. Social entertainment services are delivered through mobile apps migme, artist management community alivenotdead, social news site. The Company is listed and registered in Australia. Headquarters are in Singapore with offices in Malaysia, Indonesia, Taiwan and Hong Kong. Strategic investors include Hon Hai Precision Industry Co., Ltd., trading as Foxconn Technology Group, the Taiwanese multinational electronics contract manufacturing company. For more information, please visit company.mig.me


Forward-Looking Statements 
Forward-looking Statements: Certain matters discussed in this announcement contain statements, estimates and projections that involve risks to and uncertainties in Solaris Power Cells, Inc. business that may cause actual results to differ materially from those anticipated by the statements made herein. Such statements, estimates and projections constitute forward-looking statements within the meaning of the federal securities laws. Solaris Power Cells, Inc. undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. The recipient of this information is cautioned not to place undue reliance on forward-looking statements. No representations or warranties are made as to the accuracy of such forward-looking statements or whether any of the projections included herein will be realized.


Contact Information


For Further Information:
Solaris Power Cells, Inc.


http://www.solarispowercells.com



http://www.pixelmags.com 


Neil Kleinman
 CEO-Investor Relations


Tel: 1-619-629-0922


Email: nkleinman@pixelmags.com

Solaris Power Cells, Inc (SPCL) Stock Research Links

SPCL Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

Updated Category News Views 43

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Continue Reading
Duolingo Faces Lawsuit Over Alleged Investor Missteps

Updated Category News Views 47

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

Continue Reading
2026 Community Impact Week: Slam Dunk for Community Unity

Updated Category News Views 38

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

Continue Reading
Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

Updated Category News Views 44

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

Continue Reading
LEGO Mashes Star Wars and Marvel for Fans' Delight

Updated Category News Views 38

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

Continue Reading
Pacira BioSciences Faces Shareholder Revolt in M&A Deal

Updated Category News Views 4

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

Continue Reading
Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Updated Category News Views 35

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Continue Reading

Top 5 Most Recently Viewed Articles

Investigation Launched into AppLovin Corporation's Alleged Fraud

Updated Category News Views 386

Investigation into AppLovin Corporation In recent news, a substantial class action lawsuit has emerged against AppLovin Corporation (NASDAQ: APP). This national law firm, known for advocating for investors, aims to hold the company accountable for alleged securities law violations. Understanding the Class Action Lawsuit This lawsuit pertains to any individuals or entities...

Continue Reading
Safe Harbor Financial Expands Support for Cannabis Operators

Updated Category News Views 33

Safe Harbor Financial Takes Bold Step in Cannabis Financing In a remarkable move, Safe Harbor Financial has successfully arranged a secured credit facility valued at $1.07 million. This milestone supports a cannabis operator, marking a significant step in bolstering financial services within the cannabis industry. With their expertise in facilitating innovative financial...

Continue Reading
Nidec Corporation Faces Securities Investigation: Key Insights

Updated Category News Views 224

Understanding Nidec Corporation's Current Challenges Nidec Corporation is undergoing scrutiny due to serious allegations in its business practices. This Japanese manufacturer, known for its electronic components, faces potential claims of issuing misleading information to its investors. Recent developments have raised questions about its transparency and accountability in...

Continue Reading
Understanding HCI Group's Short Interest Trends and Insights

Updated Category News Views 126

An Overview of HCI Group's Short Interest HCI Group's short interest has sparked interest among traders and investors alike, showing a recent increase of 7.38% from the previous report. This shift indicates that there are currently around 404 thousand shares sold short, comprising 4.95% of the company’s total tradable shares. Observing the trading volume, it has been...

Continue Reading
Fresenius Kabi Introduces New Epinephrine Injection for Patients

Updated Category News Views 151

Fresenius Kabi Launches Epinephrine Injection, USP Fresenius Kabi, a proud branch of the Fresenius organization, has taken a significant step in enhancing its pharmaceutical portfolio in the United States by making available Epinephrine Injection, USP. This launch positions Fresenius Kabi at the forefront as it becomes the first company to offer a generic 1mg/1mL vial of...

Continue Reading